NATR
NATURES SUNSHINE PRODUCTS INC
Key Financials
Operating Income
$24.7M
↑ 23.1%
Net Income
$19.5M
↑ 153.7%
Gross Profit
$347.7M
↑ 7.1%
Revenue
$480.1M
↑ 5.7%
EPS (Diluted)
$1.06
↑ 165.0%
Total Assets
$261.1M
↑ 8.4%
Shareholders' Equity
$105.3M
↓ 9.0%
Total Liabilities
$99.6M
↑ 24.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 3/27/2026 | View on SEC |
| DEF 14A | 3/27/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | NATR |
| Company Name | NATURES SUNSHINE PRODUCTS INC |
| CIK | 275053 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | UT |
| Phone | (801) 341-7900 |